Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > 2 dollars in march .fried chicken says

<< Previous

Bullboard Posts

Next >>

Comment by FriedChickenon Feb 07, 2021 12:28pm

80 Views

Post# 32495844

RE:RE:RE:RE:RE:RE:RE:RE:2 dollars in march .fried chicken says

That is now seven useless posts in a row....on a Sunday! So, you've been like this for over a decade? Do you have someone to talk to, to help you work through your issues? I could refer you to someone if you'd like.

Cheers,
FC

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading